vs
FIRST US BANCSHARES, INC.（FUSB）与RYTHM, Inc.（RYM）财务数据对比。点击上方公司名可切换其他公司
RYTHM, Inc.的季度营收约是FIRST US BANCSHARES, INC.的1.0倍（$10.7M vs $10.4M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -127.6%，领先148.1%），RYTHM, Inc.同比增速更快（242.0% vs 7.1%），过去两年RYTHM, Inc.的营收复合增速更高（102.6% vs 2.6%）
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
RYTHM Inc.是一家临床阶段生物制药企业，专注于研发和商业化针对罕见遗传性内分泌与代谢疾病的创新疗法，主要面向美国市场，服务存在未被满足医疗需求的儿童及成人患者群体。
FUSB vs RYM — 直观对比
营收规模更大
RYM
是对方的1.0倍
$10.4M
营收增速更快
RYM
高出234.9%
7.1%
净利率更高
FUSB
高出148.1%
-127.6%
两年增速更快
RYM
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.4M | $10.7M |
| 净利润 | $2.1M | $-13.6M |
| 毛利率 | — | 75.5% |
| 营业利润率 | 28.1% | -121.5% |
| 净利率 | 20.4% | -127.6% |
| 营收同比 | 7.1% | 242.0% |
| 净利润同比 | 24.2% | 44.1% |
| 每股收益（稀释后） | $0.36 | $-6.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUSBRYM
| Q4 25 | $10.4M | $10.7M | ||
| Q3 25 | $10.5M | $4.0M | ||
| Q2 25 | $10.3M | $2.0M | ||
| Q1 25 | $9.8M | $538.0K | ||
| Q4 24 | $9.7M | $-7.5M | ||
| Q3 24 | $10.1M | $1.9M | ||
| Q2 24 | $10.0M | $3.0M | ||
| Q1 24 | $9.9M | $2.6M |
净利润FUSBRYM
| Q4 25 | $2.1M | $-13.6M | ||
| Q3 25 | $1.9M | $-10.7M | ||
| Q2 25 | $155.0K | $-7.4M | ||
| Q1 25 | $1.8M | $-1.6M | ||
| Q4 24 | $1.7M | $-24.4M | ||
| Q3 24 | $2.2M | $-18.7M | ||
| Q2 24 | $2.1M | $-3.0M | ||
| Q1 24 | $2.1M | $4.2M |
毛利率FUSBRYM
| Q4 25 | — | 75.5% | ||
| Q3 25 | — | 34.0% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 16.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 37.6% | ||
| Q1 24 | — | 6.4% |
营业利润率FUSBRYM
| Q4 25 | 28.1% | -121.5% | ||
| Q3 25 | 23.9% | -219.8% | ||
| Q2 25 | 1.6% | -332.9% | ||
| Q1 25 | 23.8% | -687.9% | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 29.2% | -63.1% | ||
| Q2 24 | 27.4% | -28.5% | ||
| Q1 24 | 27.8% | 13.6% |
净利率FUSBRYM
| Q4 25 | 20.4% | -127.6% | ||
| Q3 25 | 18.4% | -263.8% | ||
| Q2 25 | 1.5% | -360.4% | ||
| Q1 25 | 18.1% | -302.2% | ||
| Q4 24 | 17.6% | 324.4% | ||
| Q3 24 | 22.0% | -964.4% | ||
| Q2 24 | 21.2% | -99.3% | ||
| Q1 24 | 21.3% | 163.0% |
每股收益（稀释后）FUSBRYM
| Q4 25 | $0.36 | $-6.78 | ||
| Q3 25 | $0.32 | $-5.33 | ||
| Q2 25 | $0.03 | $-3.74 | ||
| Q1 25 | $0.29 | $-0.83 | ||
| Q4 24 | $0.29 | $-24.26 | ||
| Q3 24 | $0.36 | $-17.28 | ||
| Q2 24 | $0.34 | $-3.16 | ||
| Q1 24 | $0.34 | $3.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.5M | $32.2M |
| 总债务越低越好 | $10.9M | $80.6M |
| 股东权益账面价值 | $105.6M | $13.0M |
| 总资产 | $1.2B | $106.7M |
| 负债/权益比越低杠杆越低 | 0.10× | 6.19× |
8季度趋势，按日历期对齐
现金及短期投资FUSBRYM
| Q4 25 | $73.5M | $32.2M | ||
| Q3 25 | $54.7M | — | ||
| Q2 25 | $54.0M | $41.0M | ||
| Q1 25 | $56.0M | $24.4M | ||
| Q4 24 | $47.2M | — | ||
| Q3 24 | $82.3M | $267.0K | ||
| Q2 24 | $58.2M | $57.0K | ||
| Q1 24 | $60.2M | $99.0K |
总债务FUSBRYM
| Q4 25 | $10.9M | $80.6M | ||
| Q3 25 | $10.9M | $90.6M | ||
| Q2 25 | $10.9M | $40.6M | ||
| Q1 25 | $10.9M | $10.6M | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $10.9M | $6.2M | ||
| Q2 24 | $10.8M | $4.6M | ||
| Q1 24 | $10.8M | — |
股东权益FUSBRYM
| Q4 25 | $105.6M | $13.0M | ||
| Q3 25 | $104.2M | $11.7M | ||
| Q2 25 | $101.9M | $21.0M | ||
| Q1 25 | $101.2M | $26.8M | ||
| Q4 24 | $98.6M | $28.1M | ||
| Q3 24 | $98.5M | $5.5M | ||
| Q2 24 | $93.8M | $8.5M | ||
| Q1 24 | $92.3M | $-5.5M |
总资产FUSBRYM
| Q4 25 | $1.2B | $106.7M | ||
| Q3 25 | $1.1B | $115.2M | ||
| Q2 25 | $1.1B | $69.5M | ||
| Q1 25 | $1.1B | $45.6M | ||
| Q4 24 | $1.1B | $54.0M | ||
| Q3 24 | $1.1B | $39.0M | ||
| Q2 24 | $1.1B | $39.4M | ||
| Q1 24 | $1.1B | $40.6M |
负债/权益比FUSBRYM
| Q4 25 | 0.10× | 6.19× | ||
| Q3 25 | 0.10× | 7.73× | ||
| Q2 25 | 0.11× | 1.94× | ||
| Q1 25 | 0.11× | 0.40× | ||
| Q4 24 | 0.11× | — | ||
| Q3 24 | 0.11× | 1.13× | ||
| Q2 24 | 0.12× | 0.54× | ||
| Q1 24 | 0.12× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $12.3M | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $9.1M | — |
| 自由现金流率自由现金流/营收 | 87.2% | — |
| 资本支出强度资本支出/营收 | 31.1% | — |
| 现金转化率经营现金流/净利润 | 5.79× | — |
| 过去12个月自由现金流最近4个季度 | $16.0M | — |
8季度趋势，按日历期对齐
经营现金流FUSBRYM
| Q4 25 | $12.3M | $-3.0M | ||
| Q3 25 | $4.2M | $-5.4M | ||
| Q2 25 | $3.9M | $-8.4M | ||
| Q1 25 | $1.8M | $-6.7M | ||
| Q4 24 | $7.8M | $-5.3M | ||
| Q3 24 | $1.9M | $-1.4M | ||
| Q2 24 | $2.5M | $-1.8M | ||
| Q1 24 | $825.0K | $-3.0M |
自由现金流FUSBRYM
| Q4 25 | $9.1M | — | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $2.3M | $-1.8M | ||
| Q1 24 | $-142.0K | $-3.0M |
自由现金流率FUSBRYM
| Q4 25 | 87.2% | — | ||
| Q3 25 | 34.2% | — | ||
| Q2 25 | 16.0% | — | ||
| Q1 25 | 17.2% | — | ||
| Q4 24 | 58.2% | — | ||
| Q3 24 | 12.7% | — | ||
| Q2 24 | 23.5% | -61.2% | ||
| Q1 24 | -1.4% | -115.1% |
资本支出强度FUSBRYM
| Q4 25 | 31.1% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 21.8% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 2.0% | 0.1% | ||
| Q1 24 | 9.8% | 0.1% |
现金转化率FUSBRYM
| Q4 25 | 5.79× | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 25.16× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 0.39× | -0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUSB
暂无分部数据
RYM
| Nonlicensing Revenue | $9.5M | 89% |
| Cultivation Business Discontinued Operations | $1.2M | 11% |
